Kaleidoscope Virtual Reality Glasses Pain and Anxiety Levels in Venous Blood Collection Children

NCT ID: NCT06576141

Last Updated: 2024-08-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

105 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-09-01

Study Completion Date

2025-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of our research is to investigate the effects of distracting children's attention with a kaleidoscope and virtual reality glasses during venous blood collection on perceived pain and anxiety levels.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

After obtaining the necessary institutional permissions, parents and children who come to the blood collection room will be informed about the research through the "Informed Consent Form". The research data will be collected by the researcher using a face-to-face interview technique. Before the blood collection procedure, the children and their families who will be included in the kaleidoscope group, virtual reality group and control group will be informed about the research. The kaleidoscope will be used 5 minutes before the blood collection procedure as the child who will be included in the kaleidoscope group sits in the patient chair. The nurse will start preparing the child for the blood collection procedure at that time. The nurse will apply a tourniquet and determine the vein from the antecubital region to be taken from. The blood collection procedure will be taken from the antecubital region by the same nurse in one go using a vakuteynir (vacuum blood collection tube) and blood coming to the Vakuteynir within 5 seconds will indicate that the procedure was successful. This procedure will take approximately 2-3 minutes and the children will watch the kaleidoscope throughout the procedure. After the procedure is completed, the children will be taken out of the blood collection room and taken to the waiting area and the children will be asked to determine the level of pain they felt during the procedure. The child will assess how much fear the child experienced during the blood collection procedure and the level of anxiety.

The child who will be taken into the virtual reality group will be seated in the patient chair and virtual reality will be used 5 minutes before the blood collection procedure. The nurse will start preparing the child for the blood collection procedure at that time. The nurse will perform the tourniquet application and the determination of the vein from the antecubital region from which the blood will be taken. The blood collection procedure will be performed by the same nurse in one go from the antecubital region using a vakutainer (vacuum blood collection tube) and blood coming into the vakutainer within 5 seconds will indicate that the procedure was successful. This procedure will take approximately 2-3 minutes and the children will be shown virtual reality throughout the procedure. After the procedure is completed, the children will be taken out of the blood collection room and taken to the waiting area and the children will be asked to determine the level of pain they felt during the procedure. The child will assess how much fear the child experienced during the blood collection procedure and the level of anxiety they experienced. Children in the control group will not undergo any interventional procedures. Blood collection will be arranged to be taken from the antecubital region by the same nurse via a vacutainer. After the procedure is completed, children will be taken out of the blood collection room and taken to the waiting area. After being allowed to rest for 1-2 minutes, a questionnaire will be administered to the children. The child will evaluate how much fear the child has during the blood collection procedure and what their anxiety is. Children in the control group will not undergo any interventional procedures.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Child, Only

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

There are three groups. Kaleidoscope ,Virtual Reality Glasses and control group
Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Participants Outcome Assessors
Randomization will be done via random.org.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Kaleidoscope group

The kaleidoscope will be used 5 minutes before the blood collection procedure, as the child who will be included in the kaleidoscope group sits in the patient chair. The nurse will start preparing the child for the blood collection procedure at that time.

Group Type ACTIVE_COMPARATOR

Kaleidoscope

Intervention Type OTHER

The participation of patients in this group in the study will take approximately 15-20 minutes.

virtual reality glasses

The child to be included in the virtual reality group will be seated in the patient chair and the virtual reality will be used 5 minutes before the blood collection procedure. The nurse will start preparing the child for the blood collection procedure at that time.

Group Type ACTIVE_COMPARATOR

Virtual Reality

Intervention Type OTHER

The participation of patients in this group in the study will take approximately 15-20 minutes.

control group

Children in the control group will not undergo any interventional procedures. Blood collection will be arranged to be taken from the antecubital region by the same nurse via a vacutainer.

Group Type OTHER

control

Intervention Type OTHER

The participation of patients in this group in the study will take approximately 5-10 minutes.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Kaleidoscope

The participation of patients in this group in the study will take approximately 15-20 minutes.

Intervention Type OTHER

Virtual Reality

The participation of patients in this group in the study will take approximately 15-20 minutes.

Intervention Type OTHER

control

The participation of patients in this group in the study will take approximately 5-10 minutes.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

The child must be between the ages of 9-12, The child and parents must agree to participate in the research, The child must be able to communicate and be open to communication, The child must not have any hearing, speech or vision disorders

Exclusion Criteria

The child is not within the age range specified above The child and parents do not agree to participate in the research. The child has a communication problem The child has a hearing, speech or vision disorder.
Minimum Eligible Age

9 Years

Maximum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Erzincan Binali Yildirim Universitesi

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Tuğba OLUÇ

Research Assistant

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

To Sakarya University Training and Research Hospital

Sakarya, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

tuğba oluç, nursing

Role: CONTACT

(0446) 226 6666

metin yıldız, nursing

Role: CONTACT

02642953853

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

metin yıldız

Role: primary

02642953853

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EBYU-SBF-TO-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.